Relationship between antidepressant and anxiolytic/hypnotic prescribing: A mixed-methods study

Background: Antidepressant prescribing has dramatically increased in Scotland, and the cause is unknown. Objective: To investigate if the increase in antidepressant prescribing coincided with a reduction in prescribing of anxiolytics and hypnotics; to investigate this relationship at practice level; and to explore whether general practitioners (GPs) explain the increase by their increased use for anxiety. Methods: Study design: analysis of routine prescribing data and interviews with GPs. Setting: Scottish general practices. Participants: 942 practices included in the analysis. Sixty-three GPs in 30 practices completed interviews. Main outcome measures: Quantity of antidepressants, anxiolytics, and hypnotics prescribed. Relationship at practice level between anxiolytic/hypnotic and antidepressant prescribing. Spontaneous comments by GPs about prescribing antidepressants for anxiety. Results: Antidepressant prescribing increased from 28.9 million defined daily doses (DDDs) in 1992/3 to 128.3 million in 2004/5. Anxiolytic/hypnotic prescribing fell from 64.2 million to 55.1 million DDDs. There was a weak, positive correlation between levels of antidepressant and anxiolytic/hypnotic prescribing (+0.084, p=0.010). GPs treated anxiety with antidepressants, although many described an overlap between anxiety and depression. Some spontaneously identified a relationship with benzodiazepine prescribing when asked to explain the increase in antidepressant prescribing. Conclusion: A small part of the increase in antidepressant prescribing is due to substitution for benzodiazepines to treat anxiety.

[1]  M. Sutton,et al.  Exploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analyses of routine data. , 2006, The British journal of general practice : the journal of the Royal College of General Practitioners.

[2]  D. Gunnell,et al.  Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries , 2006, British Journal of Psychiatry.

[3]  B. D'avanzo,et al.  Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000. , 2005, The Journal of clinical psychiatry.

[4]  T. Peters,et al.  Opportunity cost of antidepressant prescribing in England: analysis of routine data , 2005, BMJ : British Medical Journal.

[5]  S. Hull,et al.  Explaining variation in antidepressant prescribing rates in east London: a cross sectional study. , 2004, Family practice.

[6]  W. Mendelson,et al.  The use of trazodone as a hypnotic: a critical review. , 2004, The Journal of clinical psychiatry.

[7]  Helgi Tómasson,et al.  Antidepressants and public health in Iceland , 2004, British Journal of Psychiatry.

[8]  H. van Marwijk,et al.  Antidepressant prescription for depression in general practice in the Netherlands , 2001, Pharmacy World and Science.

[9]  P. Tyrer,et al.  Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of disease , 2003, BMJ : British Medical Journal.

[10]  Rachel Jenkins,et al.  The National Psychiatric Morbidity Surveys of Great Britain--initial findings from the Household Survey , 2003, International review of psychiatry.

[11]  S. Hutchinson,et al.  One-year follow-up of opiate injectors treated with oral methadone in a GP-centred programme. , 2000, Addiction.

[12]  M. Stark.  Drug misuse and dependence — guidelines on clinical management , 1999 .

[13]  L. Gruer,et al.  General practitioner centred scheme for treatment of opiate dependent drug injectors in Glasgow , 1997, BMJ.